Clinical Trial Update: Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts.

View source ↗

Summary

Clinical trial update describes an access protocol for infusing CD34+ enriched, T cell–depleted hematopoietic stem cell grafts; the study is no longer available…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Cancer

Snippet

Sponsor: Leland Metheny | Conditions: Hematopoietic/Lymphoid Cancer | Status: NO_LONGER_AVAILABLE